Femasys Inc (FEMY) — SEC Filings
Femasys Inc (FEMY) — 44 SEC filings. Latest: 8-K (Apr 1, 2026). Includes 32 8-K, 6 10-Q, 2 10-K.
Overview
Femasys Inc (FEMY) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 23, 2025: On December 23, 2025, Femasys Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or transactions detailed in the provided excerpt. The company is incorporated in Delaware and headquartered in Suwanee, Georgia.
Sentiment Summary
Across 44 filings, the sentiment breakdown is: 5 bearish, 38 neutral, 1 mixed. The dominant filing sentiment for Femasys Inc is neutral.
Filing Type Overview
Femasys Inc (FEMY) has filed 32 8-K, 6 10-Q, 1 S-1/A, 1 DEFA14A, 2 10-K, 1 DEF 14A, 1 10-K/A with the SEC between Feb 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (44)
Risk Profile
Risk Assessment: Of FEMY's 39 recent filings, 6 were flagged as high-risk, 7 as medium-risk, and 26 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $1,479,926 |
| Net Income | -$14,677,582 |
| Cash Position | $4,569,038 |
| Total Assets | $16,290,153 |
| Total Debt | $11,733,902 |
Key Executives
- Kathy Lee-Sepsick
Industry Context
Femasys Inc. operates in the women's health sector, specifically focusing on contraceptive and gynecological solutions. The market for long-acting reversible contraceptives (LARCs) and permanent birth control methods is growing, driven by demand for effective and convenient options. Key trends include innovation in device technology and increasing regulatory approvals for new products.
Top Tags
8-K (12) · sec-filing (10) · financials (9) · 8-k (8) · SEC Filing (6) · regulatory-filing (5) · Financials (4) · filing (4) · 10-Q (4) · delisting (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC File Number | 001-40492 | Identifies the company's filing with the SEC. |
| EIN | 11-3713499 | Employer Identification Number for Femasys Inc. |
| Net Loss | $14.68M | Increased from $13.69M in 2024 for the nine months ended September 30. |
| Sales Revenue | $1.48M | Increased 41.28% from $1.05M in 2024 for the nine months ended September 30. |
| Cash and Cash Equivalents | $4.57M | Increased from $3.45M at December 31, 2024, due to financing activities. |
| Accumulated Deficit | $141.88M | Increased from $127.20M at December 31, 2024, reflecting ongoing losses. |
| Net Cash Provided by Financing Activities | $16.06M | Crucial for funding operations, up from $1.00M in 2024. |
| Net Cash Used in Operating Activities | $14.51M | Slightly increased from $14.37M in 2024, indicating continued cash burn. |
| Common Shares Outstanding | 47,302,373 | As of September 30, 2025, significantly increased from 23,355,926 at December 31, 2024, due to equity financings. |
| Revenue Growth | 41.28% | Year-over-year increase for the nine months ended September 30. |
| Research and Development Expenses | $5.76M | Decreased from $6.05M in 2024 for the nine months ended September 30. |
| Sales and Marketing Expenses | $3.04M | Increased from $2.85M in 2024 for the nine months ended September 30. |
| Shares of Common Stock Offered | 11,428,571 | Maximum number of common shares offered in the S-1/A |
| Pre-Funded Warrants Offered | 11,428,571 | Maximum number of pre-funded warrants offered |
| Common Warrants Offered | 11,428,571 | Maximum number of common warrants offered |
Related Companies
FYS · FYNS · FEMASYS INC
Frequently Asked Questions
What are the latest SEC filings for Femasys Inc (FEMY)?
Femasys Inc has 44 recent SEC filings from Feb 2024 to Apr 2026, including 32 8-K, 6 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of FEMY filings?
Across 44 filings, the sentiment breakdown is: 5 bearish, 38 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Femasys Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Femasys Inc (FEMY) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Femasys Inc?
Key financial highlights from Femasys Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for FEMY?
The investment thesis for FEMY includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Femasys Inc?
Key executives identified across Femasys Inc's filings include Kathy Lee-Sepsick.
What are the main risk factors for Femasys Inc stock?
Of FEMY's 39 assessed filings, 6 were flagged high-risk, 7 medium-risk, and 26 low-risk.
What are recent predictions and forward guidance from Femasys Inc?
Forward guidance and predictions for Femasys Inc are extracted from SEC filings as they are enriched.